AF
XFOR icon

Allworth Financial’s X4 Pharmaceuticals XFOR Stock Holding History

Allworth Financial’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28K Sell
310
-405
-57% -$1.52K ﹤0.01% 4501
2025
Q4 		$2.86K Buy
+715
New +$2.6K ﹤0.01% 3981

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Allworth Financial's XFOR Position: Q1 2026 in Review

Allworth Financial reduced its X4 Pharmaceuticals (XFOR) stake by 57% in Q1 2026, selling an estimated $1.52K and leaving 310 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #4501.

Allworth Financial first reported a position in XFOR in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.86K in Q4 2025. 84 funds tracked by Wall St. Rank hold XFOR as of Q1 2026.

  • Allworth Financial held 310 shares of X4 Pharmaceuticals worth $1.28K as of Q1 2026.
  • Allworth Financial sold 405 X4 Pharmaceuticals shares in Q1 2026, an estimated $1.52K.
  • X4 Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4501 holding.
  • Allworth Financial first reported a position in X4 Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Allworth Financial's X4 Pharmaceuticals position peaked at $2.86K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.